WHO WE ARE

 

The Central Connecticut Hepatitis Community (CHCgroup) was formed in the late 1990's by a group of patients, under the medical advisory of Dr. George Y. Wu at the University of Connecticut Health Center, with the goal of having members obtain confidential support for patients, families of patients and interested parties in a Self Help forum. The CHCgroup monthly two hour regular public meetings are held on second Wednesdays from 7-9pm at UConn Health Center, Research Building, Room EG013, 263 Farmington Avenue, Farmington, Connecticut. At these meetings, patients, their families and other interested individuals may learn about the Hepatitis C virus (HCV), present and past treatments, upcoming cutting edge treatments and medications to treat HCV and related liver diseases and to discuss some symptoms of HCV and the treatment, and remedies that other group members have taken to reduce and sometimes suppress those symptoms.

In addition to the conversational and periodically scheduled educational segments of meetings, CHCgroup attends and supports related fundraising events, including annual LiverWalks sponsored by the Connecticut Chapter of the American Liver Foundation (CTALF), as well as running LiverFests, attending annual CTALF LiverUpdates, Educational forums sponsored by pharmaceutical companies or CTALF, and regular meetings and presentations of other support groups in Connecticut where possible. CHCgroup is completely voluntary, is not a business entity, is co-facilitated by unpaid volunteer members and has no income, no paid employees nor any staff; what you experience is the input of group members (and professional speakers when scheduled) for the betterment of those afflicted and those associated with HCV in Connecticut.

While we also maintain contact with other national and regional organizations concerned with hepatitis and we work to encourage the formation of support groups throughout the state, we sometimes share materials from and to those organizations with those who has an interest related to HCV and/or other affiliated liver diseases and maladies.

This page last updated: June 9, 2008